LUNA:VIE
H Lundbeck A/S Class A
7,72 €
arrow_upward
+1,45%(+0,11) 1D
13. stu, 17:36:00 GMT+1 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za LUNA...
Otvori
7,75 €
Najviša
7,80 €
Najniža
7,55 €
Trž. kap.
58,13 mlr.
Prosj. kol.
143,00
Količina
17,00
52-tjed. najviša
8,17 €
52-tjed. najniža
4,22 €
Broj djelatnika
5 tis.
Otvori
7,75 €
Najviša
7,80 €
Najniža
7,55 €
Trž. kap.
58,13 mlr.
Prosj. kol.
143,00
Količina
17,00
52-tjed. najviša
8,17 €
52-tjed. najniža
4,22 €
Broj djelatnika
5 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
TradingView
·
prije 1 dan
H. Lundbeck Q3 2026 Earnings Call Is Live
Morningstar
·
prije 1 dan
Strong Demand For Vyepti Drives Improved Near-Term Outlook For Lundbeck
GuruFocus
·
prije 1 dan
H. Lundbeck AS (HLUBF) (Q3 2026) Earnings Call Highlights: Raised Guidance and Strong Vyepti Momentum
Investing.com
·
prije 2 dana
Earnings call transcript: Lundbeck lifts 2026 outlook on strong Q3 growth
Profil
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
H Lundbeck A/S Class A – informacije
Glavni izvršni direktorCharl Van Zyl
Zaposlenici5 tis.
Osnovano1915
Sjedište-
SektorHealth Care
Djelatnost-
Web-lokacijalundbeck.com